ncRNA name
hsa-miR-761
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Synovial Sarcoma
Cancer site
None
Treatment type
Chemotherapy
Drug
Pazopanib
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Extracellular vesicle-encapsulated microRNA-761 enhances pazopanib resistance in synovial sarcoma.
Tissue resource
synovial sarcoma cell lines SYO-1
synovial sarcoma cell lines HS-SYII
synovial sarcoma cell lines 1273/99
synovial sarcoma cell lines YaFuSS
Experiment
qRT-PCR
Institute
National Cancer Center Hospital
Kochi Medical School
Karolinska Institute
University of Tokyo
Country
Japan
Sweden
China
Continent
Asia